Development of Glyburide Fast-Dissolving Tablets Based on the Combined Use of Cyclodextrins and Polymers

REFERENCES

• G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison. (1995). A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413–420.
   PubMed Web of Science ®Google Scholar
• R. J. Babu, and J. K. Pandit. (1999). Effect of aging on the dissolution stability of glibenclamide-β-cyclodextrin complex. Drug Dev. Ind. Pharm. 25:1215–1219.
   PubMed Web of Science ®Google Scholar
• S. E. Bartsch, and U. J. Griesser. (2004). Physicochemical properties of the binary system glibenclamide and polyethylene glycol 4000. J. Therm. Anal. Calorim. 77:555–569.
   Web of Science ®Google Scholar
• G. V. Bertageri, and K. R. Makarla. (1995). Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int. J. Pharm. 126:155–160.
   Web of Science ®Google Scholar
• H. Blume, S. L. Ali, and M. Siewert. (1993). Pharmaceutical quality of glibenclamide products: A multinational postmarket comparative study. Drug Dev. Ind. Pharm. 19:2713–2741.
   Web of Science ®Google Scholar
• M. Cirri, M. Valleri, F. Maestrelli, G. Corti, and P. Mura. (2007). Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG6000 and surfactants. Drug Deliv. 14:247–255.
   PubMed Web of Science ®Google Scholar
• D. Cordes, and B. W. Müller. (1996). Deactivation of amorphous glibenclamide during dissolution. Eur. J. Pharm. Sci. 4:187–198.
   Google Scholar
• M. T. Faucci, and P. Mura. (2001). Effect of water-soluble polymers on naproxen complexation with natural and chemically-modified-ß-cyclodextrins. Drug Dev. Ind. Pharm. 27:311–319.
   Google Scholar
• M. A. Hassan, N. M. Najib, and M. S. Suleiman. (1991). Characterization of glibenclamide glassy state. Int. J. Pharm. 67:131–137.
   Web of Science ®Google Scholar
• T. Higuchi, and K. A. Connors. (1965). Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4:117–212.
   Google Scholar
• F. Hirayama, and K. Uekama. (1999). Cyclodextrin-based controlled drug release system. Adv. Drug Deliv. Rev. 36:125–141.
   PubMed Web of Science ®Google Scholar
• M. Iwata, and H. Ueda. (1996). Dissolution properties of glibenclamide in combinations with polyvinylpyrrolidone. Drug Dev. Ind. Pharm. 22:1161–1165.
   Web of Science ®Google Scholar
• K. A. Khan. (1975). The concept of dissolution efficiency. J. Pharm. Pharmacol. 27:48–49.
   PubMed Web of Science ®Google Scholar
• C. Leuner, and J. Dressman. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50:47–60.
   PubMed Web of Science ®Google Scholar
• T. Loftsson, and H. Fririksdóttir. (1998). The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin. Int. J. Pharm. 163:115–121.
   Web of Science ®Google Scholar
• T. Loftsson, H. Fririksdóttir, A. M. Siguroardóttir, and E. Stefánsson. (1996). Drug-cyclodextrin-polymer ternary complexes. Eur. J. Pharm. Sci. 4 (Suppl. 1):S144.
   Google Scholar
• T. Loftsson, H. Frioriksdottir, A. M. Siguroadottir, and H. Ueda. (1994). The effect of water-soluble polymers on drug-cyclodextrin complexation. Int. J. Pharm. 110:169–177.
   Web of Science ®Google Scholar
• B. Masereel, R. Ouedraogo, J. M. Dogné, H. M. Antoine, P. de Tullio, B. Pirotte, L. Pochet, J. Delarge, and P. Lebrun. (1997). Synthesis and biological evaluation of sulfonylcyanoguanidines and sulphonamidonitroethylenes. Eur. J. Med. Chem. 5:453–456.
   Google Scholar
• P. Mura, G. P. Bettinetti, A. Manderioli, M. T. Faucci, G. Bramanti, and M. Sorrenti. (1998). Interactions of ketoprofen and ibuprofen with ß-cyclodextrins in solution and in the solid state. Int. J. Pharm. 166:189–203.
   Web of Science ®Google Scholar
• P. Mura, M. T. Faucci, and G. P. Bettinetti. (2001). The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci. 13:187–194.
   PubMed Web of Science ®Google Scholar
• P. Mura, F. Maestrelli, M. Cirri, S. Furlanetto, and S. Pinzauti. (2003). Differential scanning calorimetry as an analytical tool in the study of drug-cyclodextrin interaction. J. Therm. Anal. Calorim. 73:635–646.
   Web of Science ®Google Scholar
• P. Mura, N. Zerrouck, M. T. Faucci, F. Maestrelli, and C. Chemtob. (2002). Comparative study of ibuproxam complexation with amorphous ß-cyclodextrin derivatives in solution and in the solid state. Eur. J. Pharm. Biopharm. 54:181–191.
   PubMed Web of Science ®Google Scholar
• L. Ribeiro, R. A. Carvalho, D. C. Ferreira, and F. J. B. Veiga. (2005). Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. Eur. J. Pharm. Sci. 24:1–13.
   PubMed Web of Science ®Google Scholar
• L. Ribeiro, D. C. Ferreira, and F. J. B. Veiga. (2003). Physicochemical investigation of the effects of water-soluble polymers of vinpocetine complexation with β-cyclodextrin and its sulfobuthyl ether derivative in solution and solid state. Eur. J. Pharm. Sci. 20:253–266.
   PubMed Web of Science ®Google Scholar
• J. Savolainen, K. Jarvinen, H. Taipale, P. Jarho, T. Loftsson, and T. Jarvinen. (1998). Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms. Pharm. Res. 15:1696–1701.
   PubMed Web of Science ®Google Scholar
• A. Smith. (1982). Use of thermal analysis in predicting drug-excipient interactions. Anal. Proc. 19:559–561.
   Google Scholar
• K. Uekama, F. Hirayama, and T. Irie. (1998). Cyclodextrin in drug carrier system. Chem. Rev. 98:2045–2076.
   PubMed Web of Science ®Google Scholar
• M. Valleri, P. Mura, F. Maestrelli, M. Cirri, and R. Ballerini. (2004). Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev. Ind. Pharm. 30:525–534.
   PubMed Web of Science ®Google Scholar
• A. A. Van Dooren, and B. V. Duphar. (1983). Design for drug-excipient interaction studies. Drug Dev. Ind. Pharm. 9:43–55.
   Web of Science ®Google Scholar
• H. Vogelpoel, J. Welink, G. L. Amidon, H. E. Junginger, K. K. Midha, H. Moller, M. Olling, V. P. Shah, and D. M. Barends. (2004). Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification systems (BCS) literature data. J. Pharm. Sci. 93:1945–1956.
   PubMed Web of Science ®Google Scholar